FR2372632B1 - - Google Patents

Info

Publication number
FR2372632B1
FR2372632B1 FR7636431A FR7636431A FR2372632B1 FR 2372632 B1 FR2372632 B1 FR 2372632B1 FR 7636431 A FR7636431 A FR 7636431A FR 7636431 A FR7636431 A FR 7636431A FR 2372632 B1 FR2372632 B1 FR 2372632B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7636431A
Other languages
French (fr)
Other versions
FR2372632A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Priority to FR7636431A priority Critical patent/FR2372632A1/fr
Priority to BE184021A priority patent/BE862538A/xx
Priority to LU78829A priority patent/LU78829A1/xx
Priority to GB55078A priority patent/GB1560463A/en
Priority to NL7800230A priority patent/NL7800230A/xx
Priority to DE19782801867 priority patent/DE2801867A1/de
Publication of FR2372632A1 publication Critical patent/FR2372632A1/fr
Application granted granted Critical
Publication of FR2372632B1 publication Critical patent/FR2372632B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7636431A 1976-12-03 1976-12-03 Nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire Granted FR2372632A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7636431A FR2372632A1 (fr) 1976-12-03 1976-12-03 Nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire
BE184021A BE862538A (fr) 1976-12-03 1977-12-30 Nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire
LU78829A LU78829A1 (fr) 1976-12-03 1978-01-06 Procede de preparation d'un nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire et produit obtenu
GB55078A GB1560463A (en) 1976-12-03 1978-01-06 Heparin - based medicament adminstrable by the tracheo-bronchial and alveolar route
NL7800230A NL7800230A (nl) 1976-12-03 1978-01-09 Anti-coagulans.
DE19782801867 DE2801867A1 (de) 1976-12-03 1978-01-17 Antikoagulans-arzneimittel auf der basis von heparin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7636431A FR2372632A1 (fr) 1976-12-03 1976-12-03 Nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire

Publications (2)

Publication Number Publication Date
FR2372632A1 FR2372632A1 (fr) 1978-06-30
FR2372632B1 true FR2372632B1 (instruction) 1979-03-23

Family

ID=9180598

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7636431A Granted FR2372632A1 (fr) 1976-12-03 1976-12-03 Nouveau medicament a base d'heparine administrable par voie tracheo-bronchique et alveolaire

Country Status (6)

Country Link
BE (1) BE862538A (instruction)
DE (1) DE2801867A1 (instruction)
FR (1) FR2372632A1 (instruction)
GB (1) GB1560463A (instruction)
LU (1) LU78829A1 (instruction)
NL (1) NL7800230A (instruction)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4679555A (en) * 1984-08-07 1987-07-14 Key Pharmaceuticals, Inc. Method and apparatus for intrapulmonary delivery of heparin
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
CA2516322C (en) * 2002-02-18 2013-10-15 University Of Southampton Glycosaminoglycan-dnase combination therapy
EP1513502B1 (en) * 2002-02-18 2015-12-30 Ockham Biotech Limited Combination therapy for respiratory disorders
CN115629048A (zh) * 2022-10-26 2023-01-20 上海执诚生物科技有限公司 一种抗肝素干扰的丙氨酸氨基转移酶检测试剂盒及其应用

Also Published As

Publication number Publication date
FR2372632A1 (fr) 1978-06-30
NL7800230A (nl) 1979-07-11
DE2801867A1 (de) 1979-07-19
GB1560463A (en) 1980-02-06
BE862538A (fr) 1978-06-30
LU78829A1 (fr) 1978-09-18

Similar Documents

Publication Publication Date Title
DE2710069B2 (instruction)
DK33377A (instruction)
DK280276A (instruction)
DK137832C (instruction)
DE2621209C2 (instruction)
DE2640641C3 (instruction)
DK138968C (instruction)
DK136802C (instruction)
DE2634607C2 (instruction)
CS177776B1 (instruction)
DK175277A (instruction)
DK373876A (instruction)
DK307576A (instruction)
DK250677A (instruction)
DK185276A (instruction)
DE2613554A1 (instruction)
DE2611211A1 (instruction)
DK224376A (instruction)
CS178385B1 (instruction)
CS178346B1 (instruction)
CS177789B1 (instruction)
CS177435B1 (instruction)
CS177741B1 (instruction)
CS177773B1 (instruction)
CH613902A5 (instruction)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse